Srividya Swaminathan

Title: Srividya Swaminathan: Innovator in Homologous Recombination

Introduction

Srividya Swaminathan is a notable inventor based in the United States. She has made significant contributions to the field of genetic engineering, particularly in the area of homologous recombination. Her innovative methods have the potential to advance various applications in biotechnology and medicine.

Latest Patents

Although Srividya Swaminathan currently holds 1 patents, her work on "Enhanced Homologous Recombination Mediated By Lambda Recombination Proteins" showcases her expertise. This patent discloses methods for generating recombinant DNA molecules in cells using homologous recombination mediated by recombinases and similar proteins. The methods promote high-efficiency homologous recombination in bacterial cells and in eukaryotic cells, such as mammalian cells. These techniques are useful for cloning, generating transgenic and knockout animals, and gene replacement. Additionally, they facilitate subcloning large DNA fragments without the need for restriction enzymes. The methods also aid in repairing single or multiple base mutations to wild type or creating specific mutations in the genome. Furthermore, bacterial strains that are useful for high-efficiency homologous recombination are also disclosed.

Career Highlights

Srividya Swaminathan is associated with the United States of America, as represented by the Secretary, Department of Health and Human Services. Her work in this esteemed organization highlights her commitment to advancing health and human services through innovative research.

Collaborations

Some of her notable coworkers include Donald L Court and Daiguan Yu. Their collaboration in research projects has contributed to the advancement of genetic engineering techniques.

Conclusion

In summary, Srividya Swaminathan is an accomplished inventor whose work in homologous recombination has the potential to revolutionize genetic engineering. Her innovative methods and dedication to research continue to inspire advancements in biotechnology.